Who Paid My Doc Search
Menu
Product Program year 2020 Source: CMS Open Payments

Mk-8931

Drug Neuroscience

Open in the dashboard

General payments

$11,025

11 payments

Research payments

$1,520,067

198 payments

Through program year 2020, $11,025 in general payments and $1,520,067 in research payments were reported against Mk-8931 (Neuroscience).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 Research $364,744 17
2019 General $11,025 11
2019 Research $1,155,323 181

Breakdown

Who paid General payments · program year 2019
  1. Merck Sharp & Dohme Corporation $11,025 11 payments
Top recipients General payments · program year 2019
  1. Carl Regillo Ophthalmology · Plymouth Meeting, PA $3,650 33% · 2 payments
  2. Jay Duker Uveitis and Ocular Inflammatory Disease · Boston, MA $2,650 24% · 2 payments
  3. Peter Campochiaro Ophthalmology · Baltimore, MD $2,650 24% · 2 payments
  4. Darren Gitelman Behavioral Neurology & Neuropsychiatry · Park Ridge, IL $800 7% · 1 payment
  5. Jeffrey Cummings Neurology · Los Angeles, CA $350 3% · 1 payment

The top 5 of 8 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Ophthalmology $6,300 57% · 2 practitioners
  2. Uveitis and Ocular Inflammatory Disease Ophthalmology $2,650 24% · 1 practitioner
  3. Behavioral Neurology & Neuropsychiatry Psychiatry & Neurology $800 7% · 1 practitioner
  4. Neurology Psychiatry & Neurology $350 3% · 1 practitioner
  5. Clinical Neurophysiology Psychiatry & Neurology $350 3% · 1 practitioner

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Pennsylvania $3,650 33% · 1 recipient
  2. Maryland $2,650 24% · 1 recipient
  3. Massachusetts $2,650 24% · 1 recipient
  4. Illinois $800 7% · 1 recipient
  5. California $700 6% · 2 recipients

The top 5 of 7 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

Records

11 general · 198 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record